IRON Disc Medicine, Inc.

NASDAQ
$83.28

Disc Medicine, Inc. (IRON) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is a loss of $1.65 per share.

Disc Medicine Beat Consensus Estimates
Thursday, November 5, 2026 · 8:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 8:30 AM ET
Earnings Whisper
-
vs ($1.65)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $74.39

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Disc Medicine, Inc.

Disc Medicine Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases. Disc Medicine Inc., formerly known as Gemini Therapeutics Inc., is based in WAYLAND, Mass.

Sector

Healthcare

Industry

Biotechnology

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.